Historical record - last NADAC effective date: 2/16/2021
Product Information
TREXIMET 85-500 MG TABLET is a brand product labeled by Currax Pharmaceuticals LLC, priced at $133.9175 per EA under NDC 42847085009. Its NADAC has been published 107 times since Mar 4, 2020.
FDA first approved this application on Apr 15, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
500; 85 mg/1; mg/1
Manufacturer
Currax Pharmaceuticals LLCNDC
42847085009
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
2/16/2021
Active Ingredients
NAPROXEN SODIUM; SUMATRIPTAN SUCCINATEApproval Type
New Drug (NDA)
FDA Application
NDA021926FDA Approved
4/15/2008
TE Code
AB
On Market Since
4/25/2008
Pharmacological Classes
Price Statistics
The NADAC for TREXIMET 85-500 MG TABLET has been published 107 times since Mar 4, 2020, and over the history we have for it it has risen 18.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $133.9175 per EA |
|---|---|
| All-time high | $133.9175 (Mar 16, 2022) |
| All-time low | $112.8278 (Mar 4, 2020) |
| Median price | $133.9175 |
| Average price | $127.1132 |
| Largest weekly change | +9.9% (Jul 15, 2020) |
| Weeks tracked | 107 |
| Tracking since | Mar 4, 2020 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
0.0%
All
+18.7%
Last surveyed Mar 16, 2022 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Sumatriptan Succinate and Naproxen Sodium market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TREXIMET 85-500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TREXIMET 85-500 MG TABLET, manufactured by Currax Pharmaceuticals LLC, is $133.9175 per EA (NDC 42847085009), effective Mar 16, 2022.
How has the price of TREXIMET 85-500 MG TABLET changed over time?
Over the history we have for it, the NADAC for TREXIMET 85-500 MG TABLET has risen 18.7%. It has been tracked across 107 weekly CMS publications since Mar 4, 2020.
What are the highest and lowest recorded NADAC prices for TREXIMET 85-500 MG TABLET?
Since Mar 4, 2020, the NADAC for TREXIMET 85-500 MG TABLET has ranged from a low of $112.8278 (Mar 4, 2020) to a high of $133.9175 (Mar 16, 2022), with a median of $133.9175 per EA.
Are there cheaper alternatives to TREXIMET 85-500 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of TREXIMET 85-500 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TREXIMET 85-500 MG TABLET?
TREXIMET 85-500 MG TABLET (NDC 42847085009) is labeled by Currax Pharmaceuticals LLC, and CMS classifies it as a brand product.